Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.

Also called NCT07018297

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07018297
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07018297. Randomized; no masking; primary purpose treatment. Start 2028-08 (anticipated); primary completion 2028-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure
Condition
Heart Failure
Condition
Acute Decompensated Heart Failure
Intervention (Combination product)
Early Discharge with Lasix® ONYU (furosemide injection, for subcutaneous use) using SQIN-Infusor
Lead sponsor
University of Texas Southwestern Medical Center (class: other)

Record details

Record id
cardio:ct-nct07018297
Content hash
4f7404a6b6896bbbca69f5a5cc97363f015ef32293c8d6987dbdd1c69814f43a